comparemela.com
Home
Live Updates
Phallcon Trial - Breaking News
Pages:
Latest Breaking News On - Phallcon trial - Page 1 : comparemela.com
Dr Jabbour on the Results of the PhALLCON Trial in Newly Diagnosed Ph+ ALL
Elias Jabbour, MD, discusses outcomes from the phase 3 PhALLCON trial in patients with Ph-positive acute lymphoblastic leukemia.
United states
Elias jabbour
University of texas md anderson cancer center
Division of cancer medicine
Department of leukemia
Cancer medicine
Cancer center
Phallcon trial
Patients with ph positive acute lymphoblastic leukemia
FDA Approval Insights: Ponatinib in Ph+ ALL
Dr Jabbour expands on the FDA approval of ponatinib for patients with Ph-positive ALL, the agent’s mechanism of action, and data from the PhALLCON trial.
United states
Elias jabbour
Courtney flaherty
University of texas md anderson cancer center
Division of cancer medicine
Department of leukemia
Live on air
Cancer medicine
Cancer center
Onclive on air
Apple podcasts
Google podcasts
Amazon music
Fda approval of ponatinib
Patients with ph positive all
Phallcon trial
Ponatinib Advances as Frontline Therapy in Ph+ ALL: PhALLCON Study Highlights
Bijal Shah, MD, MS, and Hagop Kantarjian, MD, discuss promising results and regulatory progress for ponatinib in frontline Philadelphia-positive acute lymphoblastic leukemia treatment.
Bijal shah
Hagop kantarjian
Expert insights
Newly diagnosed
Frontline therapy
Acute lymphoblastic leukemia
Call cancer
Oph all
Ph acute lymphoblastic leukemia
Philadelphia chromosome positive acute lymphoblastic leukemia
Newly diagnosed all
Newly diagnosed acute lymphoblastic leukemia
Tki therapy
Comparative trials
Hypercvad therapy
Broad acting tki
Short Shares Post-Conference Perspectives in Acute Lymphoblastic Leukemia From ASCO and EHA 2023
Dr Short discusses data in acute lymphoblastic leukemia that were presented at the 2023 ASCO Annual Meeting and EHA Congress.
United states
Caroline seymour
University of texas md anderson cancer center
Division of cancer medicine
Department of leukemia
Takeda pharmaceuticals
Nicholas james short
Cancer medicine
Cancer center
Onclive state
Science summit
Apple podcasts
Google podcasts
Amazon music
The university of texas md anderson cancer center
Acute lymphoblastic leukemia
vimarsana © 2020. All Rights Reserved.